Related Experiment Video
Updated: Aug 3, 2026

The Perinatal Asphyxiated Lamb Model: A Model for Newborn Resuscitation
Published on: August 15, 2018
Global, regional and national perinatal and neonatal mortality
1Department of Paediatrics, Ritchie Centre for Baby Health Research, Monash University, Melbourne, Australia. victor.yu@med.monash.edu.au
Insights
Global perinatal mortality remains high, especially in developing nations. Addressing health inequalities is crucial for improving outcomes for mothers and newborns worldwide.
Area of Science:
- Global Health
- Perinatal Medicine
- Neonatal Health
Background:
- High global perinatal mortality rate (PMR) of 53/1000 and neonatal mortality rate (NMR) of 36/1000, with 7.5 and 5.1 million deaths annually, respectively.
- Developing countries bear the brunt, with significantly higher PMR (57/1000) and NMR (39/1000) compared to developed nations, accounting for 90% of livebirths and 98% of neonatal deaths.
- The Asia-Oceania region faces a disproportionately high burden, contributing half of the world's livebirths and two-thirds of neonatal deaths.
Purpose of the Study:
- To highlight the disparities in perinatal and neonatal mortality rates globally.
- To underscore the role of PMR and NMR as indicators of healthcare system quality.
- To emphasize the need for strategies addressing national and international inequalities to improve perinatal health.
Main Methods:
- Analysis of global, regional, and national perinatal and neonatal mortality statistics.
- Comparison of mortality rates between developing and developed countries.
- Examination of livebirth and neonatal death distribution across continents.
Main Results:
- Developing countries experience 5.2x higher PMR and 5.6x higher NMR than developed countries.
- Asia-Oceania reports a PMR of 53/1000 and NMR of 41/1000, with substantial numbers of births and deaths.
- Significant regional variations exist in livebirths and neonatal deaths, with Asia-Oceania and Africa having the highest figures.
Conclusions:
- Perinatal and neonatal mortality rates are critical indicators of socioeconomic and healthcare system performance.
- Urgent interventions are required to reduce the high burden of perinatal and neonatal deaths in developing countries.
- Addressing health inequalities within and between countries is paramount for achieving global improvements in perinatal health.
Abstract:
Globally, the perinatal mortality rate (PMR) is 53/1000 (7.5 million annual perinatal deaths) and the neonatal mortality rate (NMR) is 36/1000 (5.1 million annual neonatal deaths). Of the 141 million annual livebirths, 127 million (90%) are born in developing countries, which, compared to developed countries, have a higher PMR (57/1000 vs 11/1000, 5.2x) and NMR (39/1000 vs 7/1000, 5.6x). Five million annual neonatal deaths (98% of the world's total) occur in developing countries. Regional annual livebirths figures are: Asia-Oceania 76 million, Africa 31 million, Central and South America 12 million, Europe 8 million, and North America 4 million. Regional annual neonatal death figures are: Asia-Oceania 3.3 million, Africa 1.3 million, Central and South America 0.3 million, Europe 0.07 million, North America 0.03 million. The Asia-Oceania region has a PMR of 53/1000 and a NMR of 41/1000. It has half of the world's livebirths and two-thirds of the world's neonatal deaths. The PMR and NMR have often been used as an indicator of the standard of a country's social, educational and healthcare systems. Strategies, which address inequalities both within a country and between countries, are necessary if there is going to be further improvement in global perinatal health.
More Related Videos
10:55A Piglet Perinatal Asphyxia Model to Study Cardiac Injury and Hemodynamics after Cardiac Arrest, Resuscitation, and the Return of Spontaneous Circulation
Published on: January 13, 2023
04:18Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
Published on: October 10, 2025
Related Concept Videos
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Teratogenicity
Development of the Oral Microbiota